Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP
By Adam Lidgett · March 24, 2026, 7:24 PM EDT
Sarepta Therapeutics Inc. wants the full Federal Circuit to rethink a decision reviving a University of Pennsylvania gene therapy patent, saying a panel got its analysis of patent eligibility wrong....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login